Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

EPT Disclosure

27 Feb 2009 12:47

RNS Number : 0299O
Liberum Capital Limited
27 February 2009
 

** Please note that a number of disclosures have been incorrectly reported. The revised disclosures can be found in the table below. **

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS 

WITH RECOGNISED INTERMEDIARY STATUS

DEALING IN A CLIENT-SERVING CAPACITY

(Rule 38.5(a) of the Takeover Code)

1. KEY INFORMATION

Name of exempt principal trader

Liberum Capital Limited 

Company dealt in

Aricom Plc.

Class of relevant security to which the dealings being disclosed relate (Note 1)

Ordinary Shares 

Date of dealing

26th    February 2009

2. DEALINGS (Note 2)

(a) Purchases and sales

Total number of securities purchased

Highest price paid (Note 3)

Lowest price paid (Note 3)

Nil

Nil

Nil

Total number of securities sold

Highest price received (Note 3)

Lowest price received (Note 3)

70,000

0.29

0.29

(b) Derivatives transactions (other than options)

Product name, 

e.g. CFD

Long/short (Note 4)

Number of securities (Note 5)

Price per unit (Note 3)

N/A

N/A

N/A

N/A

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 5)

Exercise

price 

Type, e.g. American, European etc.

Expiry 

date

Option money

paid/received per unit (Note 3)

N/A

N/A

N/A

N/A

N/A

N/A

N/A

(ii) Exercising

Product name, e.g. call option

Number of securities 

Exercise price per unit (Note 3)

N/A

N/A

N/A

3. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

NONE

Date of disclosure

27th  February 2009

Contact name

Carl Chambers 

Telephone number

020 7100 2034

Name of offeree/offeror with which connected

Peter Hambro Plc

Nature of connection (Note 6)

Advisor

Notes

The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

  

Date 

Total Number of securities purchased

Total Number of securities sold

02/02/09

691,732

888,191

04/02/09

2,691,517

2,638,480

05/02/09

4,095,533

4,585,130

06/02/09

2,434,339

2,013,240

09/02/09

1,322,350

1,301,424

10/02/09

172,248

667,818

13/02/09

2,416,854

2,464,337

17/02/09

387,211

302,979

Items in bold reflect the revised figure.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
EMMSEIFEWSUSELE

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.